Drug Type Biosimilar |
Synonyms Orencia/CTLA-4-Fc (Alphamab), KN 018, KN018 |
Target |
Action modulators |
Mechanism CD80 modulators(Cluster of differentiation 80 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Preclinical | China | 12 Dec 2019 |